SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 353 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $607,000 | -10.9% | 6,204 | +17.6% | 0.02% | 0.0% |
Q4 2019 | $681,000 | +72.4% | 5,274 | +0.6% | 0.02% | +60.0% |
Q3 2019 | $395,000 | -49.9% | 5,244 | +1.2% | 0.02% | -53.1% |
Q2 2019 | $788,000 | +36.6% | 5,183 | +7.1% | 0.03% | +39.1% |
Q1 2019 | $577,000 | +9.7% | 4,839 | +0.4% | 0.02% | -8.0% |
Q4 2018 | $526,000 | -28.2% | 4,821 | +6.2% | 0.02% | -19.4% |
Q3 2018 | $733,000 | – | 4,541 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |